Related Experiment Videos

Five prothrombotic polymorphisms and the prevalence of premature myocardial infarction

Vanessa Roldán, Rocío González-Conejero, Francisco Marín

    Haematologica
    |March 8, 2005
    PubMed

    Insights

    Genetic variations in clotting factors play a role in early heart attacks. Combining specific factor XIII and prothrombin gene variations significantly increases myocardial infarction risk.

    Area of Science:

    • Cardiovascular Genetics
    • Thrombosis Research
    • Molecular Medicine

    Background:

    • Investigated the association between five functional hemostatic gene polymorphisms and premature myocardial infarction (MI).
    • Analyzed 281 MI patients and 530 control subjects to assess individual and combined effects of polymorphisms.

    Discussion:

    • Individual polymorphisms showed minimal impact on MI risk.
    • Simultaneous Factor XIII and prothrombin polymorphisms significantly elevated risk (OR=12.12; p=0.028).
    • Specific combinations (Factor V Leiden with prothrombin, Factor XII with prothrombin) were exclusively found in MI patients.

    Key Insights:

    • Gene-gene interactions are crucial in the pathogenesis of premature myocardial infarction.
    • Combined effects of certain hemostatic gene polymorphisms confer a substantially higher risk than individual variants.
    • Identified specific synergistic genetic risk factors for early-onset heart attacks.

    Outlook:

    • Further research into complex genetic interactions for cardiovascular disease prediction.
    • Potential for developing genetic risk scores incorporating multiple hemostatic polymorphisms.
    • Implications for personalized medicine and preventative strategies in cardiology.

    Related Concept Videos

    Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

    Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

    Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
    Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

    Anticoagulant Drugs: Low-Molecular-Weight Heparins

    Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
    Coronary Artery Disease II: Pathophysiology01:26

    Coronary Artery Disease II: Pathophysiology

    Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
    Coronary Artery Disease I: Introduction01:30

    Coronary Artery Disease I: Introduction

    Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
    Ischemic Heart Disease: Overview01:17

    Ischemic Heart Disease: Overview

    Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
    Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
    Coronary Artery Disease IV: Preventive Measures01:26

    Coronary Artery Disease IV: Preventive Measures

    Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...